Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers.

Details

Authors
  • Anne Fages
  • Talita Duarte-Salles
  • Magdalena Stepien
  • Pietro Ferrari
  • Veronika Fedirko
  • Clément Pontoizeau
  • Antonia Trichopoulou
  • Krasimira Aleksandrova
  • Anne Tjønneland
  • Anja Olsen
  • Françoise Clavel-Chapelon
  • Marie-Christine Boutron-Ruault
  • Gianluca Severi
  • Rudolf Kaaks
  • Tilman Kuhn
  • Anna Floegel
  • Heiner Boeing
  • Pagona Lagiou
  • Christina Bamia
  • Dimitrios Trichopoulos
  • Domenico Palli
  • Valeria Pala
  • Salvatore Panico
  • Rosario Tumino
  • Paolo Vineis
  • H Bas Bueno-de-Mesquita
  • Petra H Peeters
  • Elisabete Weiderpass
  • Antonio Agudo
  • Esther Molina-Montes
  • José María Huerta
  • Eva Ardanaz
  • Miren Dorronsoro
  • Kay-Tee Khaw
  • Nick Wareham
  • Ruth C Travis
  • Julie A Schmidt
  • Amanda Cross
  • Marc Gunter
  • Elio Riboli
  • Augustin Scalbert
  • Isabelle Romieu
  • Benedicte Elena-Herrmann
  • Mazda Jenab
Organisations
External organisations
  • University of Lyon
  • International Agency for Research on Cancer, World Health Organization
  • Emory University
  • Academy of Athens
  • German Institute of Human Nutrition
  • Danish Cancer Society Research Center
  • Skåne University Hospital
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Article number242
JournalBMC Medicine
Volume13
Issue number1
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes